Virica expands bioprocessing capabilities with Carleton University partnership

Virica Biotech Inc., a leading developer of cell enhancers for scaling of viral vectors and cell and gene therapies, is expanding bioprocessing services through a strategic partnership with Carleton University. Slated to open this spring, Virica’s new facility at the university multiplies the company’s capacity to provide high throughput virology services for customers looking to optimize production of their cell and gene therapies.

Virica Biotech is an OBIO® member, an alumnus of our BDSP™ program and recipient of the WiHI Leadership subsidy.

Previous
Previous

The Ottawa Hospital is the first in the world to use Vena Medical’s breakthrough stroke technology

Next
Next

Swift Medical secures new financing round to further enhance its AI-based wound care technology